(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

D'LOY PHARMA MEDICATION KIT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

D'LOY PHARMA MEDICATION KIT

ST13

US500000098394378

Class

5

Filing

98394378

Registration

8170453

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

03/11/2026

Trademark type

Word

Nice classes

5

Filing date

02/06/2024

Registration date

03/10/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/10/2026

Last transaction

03/11/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/01/2024

First use in commerce

03/01/2024

Drawing code

4

Owner type

16

Owner location

Miami, FL, US

Examiner

ZELLNER, SIERRA E

Law office

O50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

D'LOY PHARMA LLC

Representatives

Albert Bordas, Esq ALBERT BORDAS, P.A.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

First aid kits; Medication kits comprising over the counter medications being non-prescription pharmacuetical preparationsacetaminophenantihistaminesibuprofen; Kits comprised primarily of sanitizer gel and disinfecting wipes and also including sanitary masksplastic gloves and hand cream used for germ prevention; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of non-prescription medications; medical kits comprised of topical medications being first aid gel and first aid creamacetaminophenantihistaminesibuprofennon-prescription pharmaceutical preparations for the treatment of cold and flu symptomseye dropsantacidsthermometers for medical usemulti-vitamin preparations and nutritional supplementsantisepticspharmaceutical preparations for relieving gas pressure in the stomach and intestinesnon-prescription pharmaceutical preparations for paininflammationallergiesconstipationcold and flu symptomsnauseasdiarrheaacnefungal infectionweight managementheartburnvitamins and minerals deficiency

Publications

History of USPTO decisions and trademark events.

25 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/10/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/10/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

02/18/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/18/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/17/2026

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/16/2026

IUAF

USE AMENDMENT FILED

08/11/2025

EISU

TEAS STATEMENT OF USE RECEIVED

08/11/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/11/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/17/2024

PUBO

PUBLISHED FOR OPPOSITION

12/17/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/11/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/25/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

11/22/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/22/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

11/22/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/22/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/21/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/21/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/21/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/03/2024

GNRT

NON-FINAL ACTION E-MAILED

09/03/2024

CNRT

NON-FINAL ACTION WRITTEN

09/03/2024

DOCK

ASSIGNED TO EXAMINER

08/29/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/14/2024

Continuous trademark protection

Get notified about every new filing that threatens D'LOY PHARMA MEDICATION KIT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.